PF4 and systemic sclerosis: We showed that SSc patients who do not have significant amounts of anti-CXCL4 antibodies usually have HIT antibodies, as if the two types of antibodies were mutually exclusive, although this finding needs to be confirmed in larger SSc cohorts [67].